Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States.
D001702:Biopharmaceutics; D004339:Drug Compounding; D004345:Drug Industry; D006801:Humans; D007880:Legislation, Drug; D008954:Models, Biological; D004364:Pharmaceutical Preparations / Q000032:analysis / Q000592:standards; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations